## 




## 

## 



## 



## 



## 



## 



## 

|Mr Dennis<br>Dunn|Trust Chairman||||||
|---|---|---|---|---|---|---|
|Mr John Church|Deputy Chair||||||
|Mrs Lorraine Butcher|Non-Executive||||||
|Mrs Lesley Massey|Non-Executive||||||
|Mr Trevor Brocklebank|Non-Executive||||||
|Mr Les Philpott|Non-Executive||||||
|Mr Andy Vernon|Non-Executive||||||
|Mr James Sumner|Chief Executive||||||
|Mr Russ Favager|Director<br>of Finance||and|Planning|gt Deputy|Chief|
||Executive||||||
|Mrs Heather<br>Barnett|Director ofWorkforce||||||
|Mrs Julie Tunney|Director of Nursing||and Quality||||
|Mr Chris Oliver|Chief Operating|Officer (to||30.06.2020)|||
|Mr Oliver Bennett|Chief Operating|Officer (from 20.07.2020)|||||
|Mr Murray<br>Luckas|Medical Director||||||
|Mrs Denise Frodsham|Director ofStrategic||Partnerships||||



## 



## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 



## 

## 



## 

||2020/21||2019/20|||
|---|---|---|---|---|---|
||Unrestricted|Total|Unrestricted|Total||
||'000|'000|'000|'000||
|Income||||||
|Donations (note 2)|462|462|195||195|
|Legacies|78|78|305||305|
|Investment<br>Income (note 3)|12|12|13||13|
|Total|552|552|513||513|
|Expenditure||||||
|Cost ofraising Funds (Note 4)|-48|-48|-39||-39|
|Charitable<br>Activities (Note 5)|-452|-452|-251||-251|
|Tata<br>I|-500|-500|-290||-290|
|Net gains/(losses)<br>on Investments|80|80|-52||-52|
|Net Expenditure|132|132|171||171|
|Transfers between<br>Funds||||||
|Net Movement<br>in Funds|132|132|171||171|
|Reconciliation ofFunds||||||
|Total Funds Brought Forward|1,019|1,019|848||848|
|Total Funds Carried Forward|1,151|1,151|1,019||1,019|





## 

||2020/21||2019/20||
|---|---|---|---|---|
||Unrestricted|Total|Unrestricted|Total|
||'000|'000|'000|'000|
|Fixed Assets|||||
|Investments<br>(Note 7)|671|671|582|582|
|Total fixed assets|671|671|582|582|
|Current Assets|||||
|Debtors (Note 9)|47|47|27|27|
|Cash at Bank (Note 8)|532|532|448|448|
|Total current assets|579|579|475|475|
|Liabilities|||||
|Creditors falling due within one year (Note 10)|-99|-99|-38|-38|
|Total Liabilities or provisions|-99|-99|-38|-38|
|Net current assets or liabilities|480|480|437|437|
|Total net assets|1151|1151|1019|1019|
|Funds ofthe Charity (Note 11)|||||
|Unrestricted<br>Funds|1,151|1,151|1019|1019|
||1151|1,151|1019|1019|



|Dennis<br>Dorm MBEJP DL|Date 01.10.21|
|---|---|
|Chairman||
|Russ Favager|01/10/2021|
|Director of Finance and Planning:|Date ...|





## 

|||||Total funds||Prior year funds||
|---|---|---|---|---|---|---|---|
|||||'000||'000||
|Cash Flows from operating|activities:|||||||
|Net cash provided<br>by (used in) operating|||activities||134||450|
|Cash flows from Investing|Activities|||||||
|Dividends<br>from Investments|( note 3)||||12||13|
|Proceeds from sale of investments<br>(note|||7)||292||80|
|Purchase ofinvestments<br>(|note 7)||||-351||-95|
|Investment<br>fees (note 4)|||||-3||-3|
|Net cash provided<br>by(used|in)investing||activities||-50||-5|
|Change<br>in cash and cash equivalents||in year|||84||445|
|Cash and cash equivalents|as at 1st April||2020||448|||
|Cash and cash equivalents|as at 31st|March 2021|||532||448|



## 

|||||2020/21||2019/20||
|---|---|---|---|---|---|---|---|
|||||'000||'000||
|Net income/(expenditure)||for 2020/21 as|per SOFA||132||171|
|(Gains)/Loss<br>on Investments|||||-30||55|
|Dividends|||||-12||-13|
|(Increase)/Decrease|in Debtors||||-20||280|
|Increase/(Decrease)|in Creditors||||61||-34|
|Increase/(Decrease)|in Provisions||||0||-12|
|Investment<br>Fees|||||3||3|
|Net Cash provided|by/(used|in) Operating|Activities||134||450|





## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 



|Note 2r I|ncome fro|m Donations|||||
|---|---|---|---|---|---|---|
||||2020/21||2019/20||
||||'000||'000||
|Donations from public||||71||175|
|Memodial|Donations|||3D||16|
|In aid of|Fundraising|||66|||
|NH5 Charities together grants||||170|||
|garclays|Chaditable|Grant||125|||
|||||462||195|



|Note 3EInvestment|Note 3EInvestment|Income|Income|||||
|---|---|---|---|---|---|---|---|
|||||2020/21||2019/20||
|||||'000||'000||
|Dividends|on Investments||||12||13|
||||||12||13|
|Note 4:Cost of Raising|||funds|||||
|||||2020/21||2019/20||
|||||'000||'DDD||
|Investment|Managers||Fees|||||
|Fundralslng|Management||||45||36|
||||||||39|



||||2020/21|||2019/20||
|---|---|---|---|---|---|---|---|
|||Unrestricted|Total||Unrestricted|Total||
|Direct contribution<br>to Patient Welfare||||||||
|Additonal<br>Equipment|||216|216||107|107|
|Enhancement<br>ofpatient|experience||13|||23|23|
|Improvement<br>ofpatient|facilities|||||22|22|
|Direct Contdibution<br>to staff Welfare||||||||
|Educational<br>opportunites|for staff|||23||||
|Improvement<br>to staff facilites|||66|66||||
|Recognition ofstaff achievements|||45|45||12||
|snppolt costs|||75|75||74|74|
|Total Expenditure|||452|452||251|251|





|Note 6:Analysis ofSupport Costs|Note 6:Analysis ofSupport Costs|Note 6:Analysis ofSupport Costs||||ZD20/21||||||2019/20|||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||Charitable||||gasis of||Charitable|||
||||Raising|Funds||Activities||Total||Allocation|Raising Funds|Activities||Total|
||||Unrestncted|||Unrestricted|||||Unrestricted|Unrestricted|||
|||||||||||Apportionment|||||
|Governance|||||10||||10|on average fund|||||
|||||||||||balance|||||
|||||||||||Apportionment|||||
|Audit Fee|||||||||5|on averagefund|||||
|||||||||||balance|||||
|||||||||||Apportionment|||||
|Financesupport|||||||14||14|on average fund||||13|
|||||||||||balance|||||
|||||||||||Apportionment|||||
|Information||Technology|||||||5|on average fund||||10|
|||||||||||balance|||||
|||||||||||Allocated on|||||
|Human|Resources||||||55|||time and<br>average fund|32||49|81|
|||||||||||balance|||||
|Tote Is|||||48||75||123||39||74|113|



|Note 7r Fixed|Asset Movements|- Investments|20120/21||2019/20|
|---|---|---|---|---|---|
||||'ODO||'000|
|Market Value|as at 1st April 2020|||582|622|
|Add: Additions to Investments||at cost||351|95|
|Less:Sales at|carrying value|||-292|-80|
|Less: Net (loss)/gain<br>on revaluation||||30|-55|
|Market value|as at 31st March|2021||671|582|
|Historic cost|of Investments<br>at|31st March|E605K|||
|Investments|at Market value comprised:||2020/21||2019/20|
||||'OOD||'OOD|
|Equities<br>listed on UK stock exchange||||657|546|
|UK Money market investments||||14|36|
|||||671|582|
|Note 8i Analysis ofcash and cash equivalents||||||
||||2021/22||2019/20|
||||'000||'000|
|Cash in hand||||532|448|
|Total Cash end cash equivalents||||532||
||||||23|





|Note 9IAnalysis ofDebtors|Note 9IAnalysis ofDebtors|2020/21||2019/20||
|---|---|---|---|---|---|
|||000||'000||
|HMHC Gift|aid|||||
|Confirmed|Legacies||43||19|
||||47||27|



|Note 10:Analysis|ofCreditors|faging within one year|2020/21|2019/20|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||'000|'000|||||||||
|Funds due to MCHT|||99||38||||||||
||||99||38||||||||
|Note 11:Analysis|of Charitable|Funds|||||||||||
|2020/21|||Balance 9/fwd|Income||Expenditure||Transfers||losses||Fund c/fwd|
||||01.03.2020|20/21||20/21||20/21||20/21||31.03.2021|
||||'000|'000||'000||'000||'000||'000|
|Unrestricted<br>Funds|||||||||||||
|Leighton<br>Hospital|Ik Victoria Infirmary||1019||954||-902||||BD|1151|
||||1019||954||902||0||80|1'151|
|Significant<br>Balances offunds held as at 31st March 2021|||||||||||||
|Dementia<br>Appeal|||6131K||||||||||
|Leighton General|||E307K||||||||||
|Health<br>ILWell being Fund|||E235K||||||||||
|Other Funds|||E478K||||||||||
|2019/20|||Balance 8/fwd|Income||Expenditure||Transfers||losses||Fund c/fwd|
||||01.03.2019|19/20||19/2D||19/20||19/20||31.03.2020|
||||'000|'ODO||'000||'000||'000||'OOD|
|unrestricted<br>Funds|||||||||||||
|Leighton<br>Hospital|Ik Victoria Infirmary||||513||-29D||-69||17|1019|
||||||513||-290||-69||17|1019|
|Significant<br>Balances offunds held as at 31st March 2020|||||||||||||
|Dementia<br>Appeal|||6226K||||||||||
|Leighton General|||6331K||||||||||
|Cancer Services|||91K||||||||||
|Other Funds|||E371K||||||||||